This page is part of the Evidence Based Medicine on FHIR Implementation Guide (v1.0.0-ballot: STU1 Ballot 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. . For a full list of available versions, see the Directory of published versions
: GroupAssignment: Therapeutic-dose anticoagulation with heparin vs. Usual-care pharmacologic thromboprophylaxis - JSON Representation
Raw json | Download
{
"resourceType" : "EvidenceVariable",
"id" : "179784",
"meta" : {
"versionId" : "3",
"lastUpdated" : "2023-12-01T22:26:01.820Z",
"profile" : [
🔗 "http://hl7.org/fhir/uv/ebm/StructureDefinition/group-assignment"
]
},
"text" : {
"status" : "extensions",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: EvidenceVariable</b><a name=\"179784\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource EvidenceVariable "179784" Version "3" Updated "2023-12-01 22:26:01+0000" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-group-assignment.html\">GroupAssignment</a></p></div><p><b>EvidenceVariableDefinition</b>: Defined in handling and category elements <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"CodeSystem-179423.html\">Evidence Based Medicine on FHIR Implementation Guide Code System</a>#defined-in-handling-and-category)</span></p><p><b>StructureDefinition Work Group</b>: cds</p><p><b>url</b>: <code>https://fevir.net/resources/EvidenceVariable/179784</code></p><p><b>identifier</b>: FEvIR Object Identifier:\u00a0179784</p><p><b>version</b>: 1.0.0-ballot</p><p><b>name</b>: Therapeutic_dose_anticoagulation_with_heparin_vs_Usual_care_pharmacologic_thromboprophylaxis</p><p><b>title</b>: GroupAssignment: Therapeutic-dose anticoagulation with heparin vs. Usual-care pharmacologic thromboprophylaxis</p><p><b>status</b>: active</p><p><b>date</b>: 2023-12-17 16:55:23+0000</p><p><b>publisher</b>: HL7 International / Clinical Decision Support</p><p><b>contact</b>: HL7 International / Clinical Decision Support: <a href=\"http://www.hl7.org/Special/committees/dss\">http://www.hl7.org/Special/committees/dss</a></p><p><b>description</b>: Therapeutic-dose anticoagulation with heparin vs. Usual-care pharmacologic thromboprophylaxis in multi-platform RCT of anticoagulation for non-critically ill patients with COVID-19</p><h3>UseContexts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td><td><b>Value[x]</b></td></tr><tr><td style=\"display: none\">*</td><td>Evidence Communication (Details: https://fevir.net/resources/CodeSystem/179423 code evidence-communication = 'Evidence Communication', stated as 'Evidence Communication')</td><td>group-assignment <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> ()</span></td></tr></table><p><b>copyright</b>: https://creativecommons.org/licenses/by-nc-sa/4.0/</p><p><b>author</b>: Brian S. Alper: </p><h3>RelatedArtifacts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Type</b></td><td><b>Citation</b></td></tr><tr><td style=\"display: none\">*</td><td>cite-as</td><td>GroupAssignment: Therapeutic-dose anticoagulation with heparin vs. Usual-care pharmacologic thromboprophylaxis [EvidenceVariable]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 179784. Revised 2023-11-30. Available at: https://fevir.net/resources/EvidenceVariable/179784. Computable resource at: https://fevir.net/resources/EvidenceVariable/179784.</td></tr></table><p><b>handling</b>: dichotomous</p><blockquote><p><b>category</b></p><p><b>EvidenceVariableCategoryValueReference</b>: <a href=\"Group-179786.html\">Group/179786: ExposureDefinition: Therapeutic-dose anticoagulation with heparin</a> "ExposureDefinition_Therapeutic_dose_anticoagulation_with_heparin"</p><p><b>name</b>: Therapeutic-dose anticoagulation with heparin</p></blockquote><blockquote><p><b>category</b></p><p><b>EvidenceVariableCategoryValueReference</b>: <a href=\"Group-179785.html\">Group/179785: ComparatorDefinition: Usual-care pharmacologic thromboprophylaxis</a> "ComparatorDefinition_Usual_care_pharmacologic_thromboprophylaxis"</p><p><b>name</b>: Usual-care pharmacologic thromboprophylaxis</p></blockquote></div>"
},
"extension" : [
{
"url" : "http://hl7.org/fhir/uv/ebm/StructureDefinition/evidence-variable-definition",
"valueCodeableReference" : {
"concept" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "defined-in-handling-and-category",
"display" : "Defined in handling and category elements"
}
]
}
}
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
"valueCode" : "cds"
}
],
"url" : "https://fevir.net/resources/EvidenceVariable/179784",
"identifier" : [
{
"type" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v2-0203",
"code" : "ACSN",
"display" : "Accession ID"
}
],
"text" : "FEvIR Object Identifier"
},
"system" : "https://fevir.net",
"value" : "179784",
"assigner" : {
"display" : "Computable Publishing LLC"
}
}
],
"version" : "1.0.0-ballot",
"name" : "Therapeutic_dose_anticoagulation_with_heparin_vs_Usual_care_pharmacologic_thromboprophylaxis",
"title" : "GroupAssignment: Therapeutic-dose anticoagulation with heparin vs. Usual-care pharmacologic thromboprophylaxis",
"status" : "active",
"date" : "2023-12-17T16:55:23+00:00",
"publisher" : "HL7 International / Clinical Decision Support",
"contact" : [
{
"name" : "HL7 International / Clinical Decision Support",
"telecom" : [
{
"system" : "url",
"value" : "http://www.hl7.org/Special/committees/dss"
}
]
}
],
"description" : "Therapeutic-dose anticoagulation with heparin vs. Usual-care pharmacologic thromboprophylaxis in multi-platform RCT of anticoagulation for non-critically ill patients with COVID-19",
"useContext" : [
{
"code" : {
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "evidence-communication",
"display" : "Evidence Communication"
},
"valueCodeableConcept" : {
"text" : "group-assignment"
}
}
],
"copyright" : "https://creativecommons.org/licenses/by-nc-sa/4.0/",
"author" : [
{
"name" : "Brian S. Alper"
}
],
"relatedArtifact" : [
{
"type" : "cite-as",
"citation" : "GroupAssignment: Therapeutic-dose anticoagulation with heparin vs. Usual-care pharmacologic thromboprophylaxis [EvidenceVariable]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 179784. Revised 2023-11-30. Available at: https://fevir.net/resources/EvidenceVariable/179784. Computable resource at: https://fevir.net/resources/EvidenceVariable/179784."
}
],
"handling" : "dichotomous",
"category" : [
{
"extension" : [
{
"url" : "http://hl7.org/fhir/uv/ebm/StructureDefinition/evidence-variable-category-value-reference",
"valueReference" : {
🔗 "reference" : "Group/179786",
"type" : "Group",
"display" : "ExposureDefinition: Therapeutic-dose anticoagulation with heparin"
}
}
],
"name" : "Therapeutic-dose anticoagulation with heparin"
},
{
"extension" : [
{
"url" : "http://hl7.org/fhir/uv/ebm/StructureDefinition/evidence-variable-category-value-reference",
"valueReference" : {
🔗 "reference" : "Group/179785",
"type" : "Group",
"display" : "ComparatorDefinition: Usual-care pharmacologic thromboprophylaxis"
}
}
],
"name" : "Usual-care pharmacologic thromboprophylaxis"
}
]
}
|
Propose a change